GILD vs OPXS · P/E 18, rev $7.80B vs P/E 17, rev $28.5M
Gilead Sciences Inc (GILD) versus Optex Systems Holdings, Inc. Common Stock (OPXS) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Optex Systems Holdings, Inc. Common Stock (OPXS) is a aerospace & defense company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported OPXS revenue for 2026-06-28 was $28.5M. Net income was $2.9M. Revenue was up 51.8% from 2026-03-29 to 2026-06-28. OPXS currently screens at market cap $81.2M and trailing P/E 16.5.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. OPXS currently screens at market cap $81.2M and trailing P/E 16.5.
Not investment advice. Open the GILD and OPXS stock pages for the full models.
Not investment advice.